Home » Topics » Regulatory

Regulatory
RSS

More convenient formulation of Lodine approved

Nov. 8, 1996

No Comments

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

No Comments

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

No Comments

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

No Comments

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

No Comments

Cefzil approved for new indication in U.S.

Nov. 1, 1996

No Comments

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Oct. 25, 1996

No Comments

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

No Comments

Expanded indications for Abelcet

Oct. 25, 1996

No Comments

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

More convenient formulation of Lodine approved

IL-2 treatment dramatically effective in AIDS patients

MiKasome cleared for clinical trials in HIV-positive patients

New, more convenient testosterone transdermal patch submitted for approval

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Cefzil approved for new indication in U.S.

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Sulfasalazine approved for rheumatoid arthritis

Expanded indications for Abelcet

Cholestyramine treatment of peri-anal irritation in an infant

Today's news in brief

Today's news in brief

Aurinia Therapeutics’ AUR-300 proven useful in systemic sclerosis

‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s

Astrazeneca’s AKT inhibitor is approved in breast cancer

Regulatory RSS

Regulatory
RSS